Suchergebnisse - "Wang, Qixue"

PubPharm (105)

1

EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma

enthalten in: Cancer letters | 2024

von Yang, E. | Hong, B. | Wang, Y. | +8

2

Levetiracetam : A Potent Sword against Microglia Polarization in Gliomas

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Cui, X. | Wang, Q. | Liu, X. | +1

3

RUNX1/NPM1/H3K4me3 complex contributes to extracellular matrix remodeling via enhancing FOSL2 transcriptional activation in glioblastoma

enthalten in: Cell death & disease | 2024

von Cui, X. | Huo, D. | Wang, Q. | +6

4

Retraction of "Universal theranostic CRISPR/Cas13a RNA-editing system for glioma"

enthalten in: Theranostics | 2024

von Wu, Y. | Wang, Y. | Zhou, J. | +10

RetractionOf: Theranostics. 2023 Sep 25;13(15):5305-5321. - PMID 37908718

5

EPIC-1042 as a potent PTRF/Cavin1-caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma

enthalten in: Neuro-oncology | 2024

von Hong, B. | Yang, E. | Su, D. | +15

ErratumIn: Neuro Oncol. 2023 Dec 8;25(12):2306-2308. - PMID 37931238

6

Small molecule compound EPIC-1042, pharmaceutical composition, and preparation method and application of small molecule compound EPIC-1042

enthalten in: Europäisches Patentamt | 2024

von KANG CHUNSHENG | HONG BIAO | WANG QIXUE | +2

7

Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma

enthalten in: Cancer communications (London, England) | 2023

von Cui, X. | Zhao, J. | Li, G. | +15

8

EPIC-0307-mediated selective disruption of PRADX-EZH2 interaction and enhancement of temozolomide sensitivity to glioblastoma via inhibiting DNA repair and MGMT

enthalten in: Neuro-oncology | 2023

von Xin, L. | Tan, Y. | Zhu, Y. | +12

9

Exosomes : Potential key players towards novel therapeutic options in diabetic wounds

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Feng, J. | Yao, Y. | Wang, Q. | +6

10

CRISPR/Cas13a system-based crRNA specifically targeting IDH1 R132H gene and application thereof

enthalten in: Europäisches Patentamt | 2023

von KANG CHUNSHENG | WU YE | WANG YUNFEI | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]